CELMoD™ Agents for the Treatment of Multiple Myeloma

Speaker(s)

• 

  Michael D. Amatangelo, PhD

  Scientific Director, Translational Medicine
  Bristol Myers Squibb, Summit, NJ, USA
  Summit, New Jersey